Viraday is a medication that contains the active ingredients Efavirenz, Tenofovir, and Emtricitabine. It is manufactured by Cipla Ltd. and comes in the form of tablets. Each tablet contains Efavirenz 600 mg, Tenofovir 300 mg, and Emtricitabine 200 mg. The drug is used for the treatment of HIV-1 infection in adult patients.
Efavirenz, Tenofovir, and Emtricitabine are antiretroviral medications that belong to the class of non-nucleoside reverse transcriptase inhibitors (NNRTIs) and nucleotide reverse transcriptase inhibitors (NRTIs). These drugs work to inhibit the activity of the reverse transcriptase enzyme, which is necessary for the virus to replicate and spread in the body. By blocking this enzyme, the medications prevent the virus from multiplying and causing damage to the immune system.
Viraday is used in combination with other antiretroviral medications to treat HIV-1 infection in adult patients. The drug is often given to patients who have not received previous treatment for the virus or who have experienced treatment failure. Viraday is also used in the prevention of mother-to-child transmission of HIV-1 infection.
The recommended dosage of Viraday is one tablet taken once a day, with or without food. The tablet should be swallowed whole with water and should not be crushed or chewed.
As with any medication, Viraday may cause side effects in some patients. The most common side effects of the drug include dizziness, drowsiness, abnormal dreams, nausea, vomiting, diarrhea, and changes in the levels of liver enzymes. Severe side effects may also occur, such as allergic reactions, liver problems, and lactic acidosis. Patients who experience any unusual symptoms after taking Viraday should consult with their doctor immediately.
Viraday is a prescription medication, and patients should only take it under the guidance of a healthcare professional. Before taking the drug, patients should inform their doctor of any existing medical conditions or medications they are taking. The drug may interact with certain medications, such as rifampicin and methadone, so patients should let their doctor know if they are taking any other drugs.
In conclusion, Viraday is a medication used for the treatment of HIV-1 infection in adult patients. It contains Efavirenz, Tenofovir, and Emtricitabine, which work to inhibit the activity of the reverse transcriptase enzyme necessary for the virus to replicate and spread in the body. Viraday is effective in patients who have not received previous treatment for the virus and may cause side effects in some patients. Patients should only take Viraday under the guidance of a healthcare professional and should inform their doctor of any existing medical conditions or medications they are taking.
Reviews
There are no reviews yet.